Similar companies
| Company | Revenue | |
|---|---|---|
| No data for previous quarter available yet. | ||
Income Statement (NONE)
| Q1 '25 | QoQ | |
|---|---|---|
| Operating expense | 1.8M | 0% |
| Net Income | 6.5M | 2183.4% |
| EBITDA | 3.9M | 0% |
Balance Sheet (NONE)
| Q1 '25 | QoQ | |
|---|---|---|
| Total Assets | 900,000 | 0% |
| Total Liabilities | 99M | 0% |
| Shares Outstanding | 28M | 21.1% |
Cash Flow (NONE)
| Q1 '25 | QoQ | |
|---|---|---|
| Cash from operations | -2.5M | 0% |
| Cash from financing | 2.5M | 0% |
EPS
Financial Highlights for Ocean Biomedical in Q1 '25
Operating Expenses for this period were 1.8M, showing a 0% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 6.5M, showing a 2183.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 3.9M, showing a 0% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
The company's performance remained stable this quarter with no significant positive or negative changes in the key financial metrics.
